Dapagliflozin for the treatment of adults with chronic kidney disease (Review of TA775): Cost comparison evaluation process

Research output: Book/Report › Commissioned report

Original language	English
Publisher	National Institute for Health and Care Excellence
Publication status	Published - 5 Sept 2024

Cite this

@book{f5b8d57cd575499797b0b5fa8b9e576f,

title = "Dapagliflozin for the treatment of adults with chronic kidney disease (Review of TA775): Cost comparison evaluation process ",

author = "Perry, {Mark Christopher} and Alexis Llewellyn and Joseph Lord and Melissa Harden and Natalia Kunst and Nevitt, {Sarah Jane}",

year = "2024",

month = sep,

day = "5",

language = "English",

publisher = "National Institute for Health and Care Excellence",

}

TY - BOOK

T1 - Dapagliflozin for the treatment of adults with chronic kidney disease (Review of TA775)

T2 - Cost comparison evaluation process

AU - Perry, Mark Christopher

AU - Llewellyn, Alexis

AU - Lord, Joseph

AU - Harden, Melissa

AU - Kunst, Natalia

AU - Nevitt, Sarah Jane

PY - 2024/9/5

Y1 - 2024/9/5

M3 - Commissioned report

BT - Dapagliflozin for the treatment of adults with chronic kidney disease (Review of TA775)

PB - National Institute for Health and Care Excellence

ER -